Cancer predisposition in diabetics: Risk factors considered for predictive diagnostics and targeted Preventive measures

EPMA Journal

Volumn 1, Issue 1, 2010, Pages 130-137

  Cebioglu, Melanie ^a   Schild, Hans H ^a   Golubnitschaja, Olga ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Advanced technologies; Cancer in diabetes; Preventive diagnostics; Prognostic risk factors; Stress viral etiology; Targeted preventive measures

Indexed keywords

MITOCHONDRIAL DNA; MYC PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL KINETICS; CHROMOSOME DAMAGE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEOPLASM; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 77957608607     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0015-4     Document Type: Article

References (88)

1. Mozaffari MS, Abdelsayed R, Schaffer SW. Diabetic complications: pathogenic mechanisms and prognostic indicators. In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers; 2009.
2. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856-62.
3. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365-74.
4. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679-87.
5. Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomark Prev. 2006;15:1458-63.
6. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991;2:307-14.
7. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871-7.
8. Zendehdel K, Nyrén O, Ostenson CG, et al. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst. 2003;95:1797-800.
9. Verlato G, Zoppini G, Bonora E, et al. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care. 2003;26:1047-51.
10. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007;2007:43603.
11. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120:1986-92.
12. Coughlin SS, Calle EE, Teras LR, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159:1160-7.
13. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194-202.
14. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86:823-35.
15. Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer. 2005;92:2070-5.
16. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev. 2007;28:763-77.
17. Mori M, Saitoh S, Takagi S, et al. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev. 2000;1:269-76.
18. Chung YW, Han DS, Park KH, et al. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum. 2008;51:593-7.
19. Larsson SC, Orsini N, Brismar K, et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49:2819-23.
20. Suba Z, Ujpál M. Disorders of glucose metabolism and risk of oral cancer. Fogorv Sz. 2007;100:250-7.
21. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360-5.
22. Vairaktaris E, Kalokerinos G, Goutzanis L, et al. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis. Anticancer Res. 2007;27:1465-73.
23. Drechsler K, Fikenzer S, Sechtem U, et al. The Euro Heart Survey - Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol. 2008;97:364-70.
24. Hofmann MA, Schiekofer S, Isermann B, et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia. 1999; 42:222-32.
25. Bierhaus A, Schiekofer S, Schwaninger M, et al. Diabetesassociated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 2001;50:2792-808.
26. Palmeira CM, Rolo AP, Berthiaume J, et al. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol. 2007;225:214-20.
27. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-12.
28. Ricci C, Pastukh V, Mozaffari M, et al. Insulin withdrawal induces apoptosis via a free radical-mediated mechanism. Can J Physiol Pharmacol. 2007;85:455-64.
29. Hou N, Torii S, Saito N, et al. Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases. Endocrinology. 2008;149:1654-65.
30. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res. 2000;87:1123-32.
31. Golubnitschaja O. Diabetes mellitus. In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers; 2009.
32. Ohta S. A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease. Curr Med Chem. 2003;10: 2485-94.
33. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167-78.
34. Golubnitschaja O. Clinical proteomics in application to predictive diagnostics and personalized treatment of diabetic patients. Curr Proteomics. 2008;5:35-44.
35. Xu L, Hu Y, Chen B, et al. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer. 2006;16:1661-7.
36. Alexeyev MF, Ledoux SP, Wilson GL. Mitochondrial DNA and aging. Clin Sci. 2004;107:355-64.
37. Bai RK, Leal SM, Covarrubias D, et al. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007;67:4687-94.
38. Bener A, Micallef R, Afifi M, et al. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol. 2007;18:225-9.
39. Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J Diabetes Complicat. 2007;21:403-6.
40. Ojetti V, Migneco A, Silveri NG, et al. The Role of H. pylori Infection in Diabetes. Curr Diabetes Rev. 2005;1:343-7.
41. Foss NT, Foss-Freitas MC, Ferreira MA, et al. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients. Diabetes Metab. 2007;33:439-43.
42. Hopps E, Camera A, Caimi G. Polimorphonuclear leukocytes and diabetes mellitus. Minerva Med. 2008;99:197-202.
43. Barnea M, Madar Z, Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun. 2008;367:452-6.
44. Ali SS, Ali IS, Aamir AH, et al. Frequency of hepatitis C infection in diabetic patients. J Ayub Med Coll Abbottabad. 2007;19:46-9.
45. Sangiorgio L, Attardo T, Gangemi R, et al. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract. 2000;48:147-51.
46. Banerjee S, Banerjee M. Hepatitis C and diabetes mellitus. J Indian Med Assoc. 2006;104:86-9.
47. Shera KA, Shera CA, McDougall JK. Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol. 2001;75:12339-46.
48. Popescu NC, Zimonjic DB. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med. 2002;6: 151-9.
49. de Villiers EM, Sandstrom RE, zur Hausen H. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005;7:1-11.
50. Lawson JS, Günzburg WH, Whitaker NJ. Viruses and human breast cancer. Future Microbiol. 2006;1:33-51.
51. Hemann MT, Narita M. Oncogenes and senescence: breaking down in the fast lane. Genes Dev. 2007;21:1-5.
52. Ben-Yosef T, Yanuka O, Halle D, et al. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 1998;17:165-71.
53. Pontén J, Guo Z. Precancer of the human cervix. Cancer Surv. 1998;32:201-29.
54. Johnson CN, Levy LS. Matrix attachment regions as targets for retroviral integration. Virol J. 2005;2:68.
55. Hebner CM, Laimins LA. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol. 2006;16:83-97.
56. Golubnitschaja O. Cell cycle checkpoints: the role and evaluation for diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids. 2007;32:359-71.
57. Cebioglu M, Schild HH, Golubnitschaja O. Diabetes mellitus as risk factor for cancer: stress or viral etiology? Infect Disord Drug Targets. 2008;8:76-87.
58. Berger FG. The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality. Breast Cancer Res Treat. 2004;88:281-5.
59. Di Pietro PF, Medeiros NI, Vieira FG, et al. Breast cancer in southern Brazil: association with past dietary intake. Nutr Hosp. 2007;22:565-72.
60. Fejerman L, Ziv E. Population differences in breast cancer severity. Pharmacogenomics. 2008;9:323-33.
61. Celis JE, Moreira JM, Cabezón T, et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics. 2005;4:492-522.
62. Xue Y, Guo XT, Liu WC. Clinical research advancement on male breast cancer. Ai Zheng. 2007;26:1148-52.
63. Benchellal Z, Wagner A, Harchaoui Y, et al. Male breast cancer: 19 case reports. Ann Chir. 2002;127:619-23.
64. Riedl M, Kotzmann H, Luger A. Growth hormone in the elderly man. Wien Med Wochenschr. 2001;151:426-9.
65. Abu-Abid S, Szold A, Klausner J. Obesity and cancer. J Med. 2002;33:73-86.
66. Kruk J. Physical activity in the prevention of the most frequent chronic diseases: an analysis of the recent evidence. Asian Pac J Cancer Prev. 2007;8:325-38.
67. Irigaray P, Newby JA, Clapp R, et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother. 2007;61:640-58.
68. Danaei G, Vander Hoorn S, Lopez AD, et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784-93.
69. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem. 2005;95:649-56.
70. Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008;6:275- 82.
71. Hermansen K, Jørgensen K, Schmidt EB, et al. Alcohol and lifestyle diseases. Ugeskr Laeg. 2007;169:3404-6.
72. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
73. Gago-Dominguez M, Jiang X, Castelao JE. Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res. 2007;9:201.
74. Saikali J, Picard C, Freitas M, et al. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer. 2004;49:14-24.
75. Bonassi S, Znaor A, Norppa H, et al. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet Genome Res. 2004;104:376-82.
76. Loizidou MA, Michael T, Neuhausen SL, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat. 2008;112:575-9.
77. Mahabir S, Wei Q, Barrera SL, et al. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008;29:949-56.
78. Yu D, Zhang X, Liu J, et al. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Clin Cancer Res. 2008;14:2878-86.
79. Munday R, Zhang Y, Fahey JW, et al. Evaluation of isothiocyanates as potent inducers of carcinogen-detoxifying enzymes in the urinary bladder: critical nature of in vivo bioassay. Nutr Cancer. 2006;54:223-31.
80. Moenkemann H, De Vriese AS, Blom HJ, et al. Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids. 2002;23:331-6.
81. Howard RA, Freedman DM, Park Y, et al. Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2008;19:939-53.
82. Gahan PB. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer. Infect Disord Drug Targets. 2008;8:100-8.
83. Golubnitschaja O. Advanced technologies for prediction of secondary complications in diabetes mellitus. In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers; 2009.
84. Cebioglu M, Schild HH, Golubnitschaja O. Diabetes mellitus as a risk factor for cancer: is predictive diagnosis possible? In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers; 2009.
85. Golubnitschaja O. Advanced diabetes care: three levels of prediction, prevention & personalized treatment. Curr Diabetes Rev. 2010;6:42-51.
86. Page NM, Kemp CF, Butlin DJ, et al. Placental peptides as markers of gestational disease. Reproduction. 2002;123:487-95.
87. Schweigert FJ. Nutritional proteomics: methods and concepts for research in nutritional science. Ann Nutr Metab. 2007;51:99-107.
88. Mathers JC, Hesketh JE. The biological revolution: understanding the impact of SNPs on diet-cancer interrelationships. J Nutr. 2007;137:253S-8S.